baber/WOPTO huggingface dataset:
Patent DK-1884158-T3 (DK)
Inventor: ROMEU GUARDIA GENER
IPC: A01K5/02
Filed: 2007-07-20
Granted: 2011-09-12
Abstract: A feeder (5) for animals which consists of a feed storage tank (3) equipped with at least one chute (6) at its base, through which the feed falls due to the force of gravity, and a corresponding distribution tray (2) arranged beneath the chute (6) of the tank (3) and whereon the feed coming from said tank collects; the feeder also comprises a supporting body (7) for the distribution tray (2), an operating lever (4) for said distribution tray and an articulated means (8) for the joining of the operating lever (4) to the aforementioned supporting body, the operating lever (4) being arranged beneath the distribution tray (2), where it may easily be moved by an animal.
Patent DK-2316837-T3 (DK)
Inventor: CHAPMAN ROBERT
IPC: C07D489/08
Filed: 2005-03-30
Granted: 2018-04-16
Abstract: In certain embodiments the invention is directed to a pharmaceutical dosage form comprising an oxycodone hydrochloride composition having less than 25 ppm of 14-hydroxycodeinone.
Patent DK-2311432-T3 (DK)
Inventor: LADNER ROBERT CHARLES
IPC: C12N15/15
Filed: 2003-06-06
Granted: 2015-02-02
Abstract: A polypeptide comprising the amino acid sequence: Met His Ser Phe Cys Ala Phe Lys Ala Asp Asp Gly Pro Cys Arg Ala Ala His Pro Arg Trp Phe Phe Asn Ile Phe Thr Arg Gln Cys Glu Glu Phe Ile Tyr Gly Gly Cys Glu Gly Asn Gin Asn Arg Phe Glu Ser Leu Glu Glu Cys Lys Lys Met Cys Thr Arg Asp (amino acids 3-60 of SEQ ID NO:2), wherein the polypeptide inhibits kallikrein.
Patent DK-3003330-T3 (DK)
Inventor: JONES LEE A
IPC: A61P1/00
Filed: 2014-06-04
Granted: 2018-08-20
Abstract: Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag.
Patent DK-2968010-T3 (DK)
Inventor: SHORE SUSAN
IPC: H04R25/00
Filed: 2014-03-17
Granted: 2018-05-22
Abstract: Timed stimulation of both somatosensory system and auditory system is controlled, in such a manner, that an individual's brain activity is altered through spike-timing dependent plasticity, thereby reducing or removing tinnitus.
Patent DK-0480135-T3 (DK)
Inventor: PALLOR HANS FRITZ DIPL ING
IPC: E06B7/23
Filed: 1991-07-23
Granted: 1994-12-27
Abstract: The invention relates to a contact profile, in particular for shielded doors with frames for shielded rooms. To achieve the object of improving a contact profile of this type in such a way as to ensure a functional suitability even for a long use time, there is provided in a holder (18; 34) a prestressed rubber-elastic spring (32) whose outer surface is covered by an HF sealing plate (30). <IMAGE>
Patent DK-0480391-T3 (DK)
Inventor: GOEPFERICH ACHIM DR
IPC: A61K9/22
Filed: 1991-10-09
Granted: 1996-04-22
Abstract: The invention relates to emulsifier-free emulsion polymers, to their production and to their use in pharmaceutical compositions with delayed release of active substance.
Patent DK-0479561-T3 (DK)
Inventor: MITO KAZUNORI
IPC: B32B15/085
Filed: 1991-10-01
Granted: 1995-12-27
Abstract: A process for preparing a laminate comprising coating the surfaces of a metal substrate that has been treated with an anchor coating agent with a modified polyolefin type resin and heat-adhering the olefin type resin onto the surfaces of the metal substrate, wherein the laminate is heat-treated during or after adhesion in the presence of a treating agent, the treating agent comprising at least one of a compound of the formula: R<1> - Y - R<2>   (1)    wherein R<1> is a substituted or unsubstituted monovalent hydrocarbon group, Y is an oxygen atom, a sulfur atom or a group NR<2>, and R<2> is a hydrogen atom or a substituted or unsubstituted monovalent hydrocarbon group,     or of the formula: <CHEM> wherein R<3> is a substitute.d or unsubstituted monovalent hydrocarbon group, and Z is an oxygen atom, a sulfur atom, or a group represented by the formula: = N - R<9>   (3)    (wherein R<9> is a hydrogen atom or a substituted or unsubstituted monovalent hydrocarbon group), and R<4> is a hydrogen atom, an amino group, a substituted or unsubstituted monovalent hydrocarbon group, or a group represented by the formula: - OR<5>   (4)    (wherein R<5> is a hydrogen atom or a substituted or unsubstituted monovalent hydrocarbon group), or a group represented by the formula: <CHEM> (wherein R<6> is a substituted or unsubstituted monovalent hydrocarbon group), and wherein when the group Z is a sulfur atom, R<4> is a substituted or unsubstituted hydrocarbon group and when the group Z is the group of formula 3, R<4> is a hydrogen atom or a substituted or unsubstituted monovalent hydrocarbon group and when R<4> is the group of formula 5 and Z is the oxygen atom, the group R<3> and the group R<6> coupled together may form a substituted or unsubstituted divalent hydrocarbon group,     or an organosilicon compound. The laminate thus prepared is able to resist deterioration in adhesion strength, particularly in atmospheres where water is present.
Patent DK-0497919-T3 (DK)
Inventor: VENKATESHWARAN SRINIVASAN
IPC: A61M37/00
Filed: 1990-10-23
Granted: 1997-06-09
Abstract: An iontophoresis device comprising a drug reservoir containing the drug in ionic form and in communication with the skin, a skin permeation enhancing agent contained in the reservoir or in a second reservoir also in communication with the skin, an electrode in contact with the drug, another electrode in contact with the skin, a D.C. power source connected to the electrodes and an electrically sensitive membrane interposed between the reservoir and the skin that is impermeable to drug in the absence of a voltage difference between the electrodes and permeable to the drug in the presence of a voltage difference. The skin permeation enhancing agent eliminates the skin as a rate-controlling element, thus making the rate of drug administration dependent upon the membrane permeability, which in turn is controlled electrically.
Patent DK-0533221-T3 (DK)
Inventor: INVERNIZZI RENZO
IPC: C08F4/60
Filed: 1992-07-17
Granted: 1995-12-27
Abstract: A supported solid component of catalyst, for the stereospecific polymerization of propylene and other  alpha -olefins, is obtained by making a non-activated silica interact in succession with: (i) a magnesium dialkyl or halide of magnesium alkyl; (ii) a halogenating agent selected from silicon, tin and antimony halides; (iii) a titanium tetrahalide: and (iv) a Lewis base. A catalyst for the stereospecific polymerization of propylene and other  alpha -olefins is composed of: (A) the solid component of catalyst; (B) an aluminium trialkyl or aluminium alkyl halide; and (C) an electron donor compound, capable of forming a complex compound with component (B).
Patent DK-0560882-T3 (DK)
Inventor: ACHARD PATRICK
IPC: C05B1/00
Filed: 1991-12-04
Granted: 1998-11-30
Abstract: PCT No. PCT/FR91/00965 Sec. 371 Date Sep. 15, 1993 Sec. 102(e) Date Sep. 15, 1993 PCT Filed Dec. 4, 1991 PCT Pub. No. WO92/10443 PCT Pub. Date Jun. 25, 1992.The method relates to the production of phospho-nitrogenous products soluble in neutral ammonium citrate and wherein free urea does not remain in significant amount in such products. Most of the free urea is involved in a ureic combination of calcium sulphate. Tricalcic phosphate is reacted with a reactant obtained by mixing sulfuric acid and urea. The process is particularly useful for the manufacture of fertilizers.
Patent DK-0557792-T3 (DK)
Inventor: BRUCHMANN BERND DR
IPC: C08G18/76
Filed: 1993-02-10
Granted: 1996-07-29
Abstract: The invention relates to a process for the production of CFC-free flexible (moulded) polyurethane foams of low density by reacting   A) liquid polyisocyanate mixtures containing bonded urethane groups and containing from 22 to 30% by weight of NCO groups, these mixtures themselves being prepared by reacting a mixture of diphenylmethane diisocyantes and polyphenylpolymethylene polyisocyanates (crude MDI) with at least one polyoxypropylene-polyoxyethylene-polyol having a functionality of from 2.5 to 3.5, a hydroxyl number of from 50 to 90 and a content of polymerised ethylene oxide groups of from greater than 30 to less than 50% by weight, based on the weight of polymerised ethylene oxide and 1,2-propylene oxide groups, or by reacting 4,4'-diphenylmethane diisocyanate (MDI) or an MDI isomer mixture with said polyoxypropylene-polyoxyethylene-polyol to give an NCO-containing quasi prepolymer and diluting this quasi prepolymer with crude MDI, with B) relatively high-molecular-weight polyhydroxyl compounds and optionally C) low-molecular-weight chain extenders and/or crosslinking agents in the presence of   D) blowing agents,   E) catalysts and optionally   F) auxiliaries and/or additives, and the urethane group-modified polyisocyanate mixtures (A) which can be used according to the invention.
Patent DK-0572039-T3 (DK)
Inventor: COX MICHAEL GRAHAM CAREY
IPC: C06F3/00
Filed: 1991-12-20
Granted: 1997-04-21
Abstract: A pyrotechnic compsn. is claimed which includes ferrophosphorus. Also claimed is the following: a safety match having a head coated in the compsn. The compsn. contains potassium chlorate, a binder, a thickener, a filler and a foaming agent to the exclusion of sulphur, ZnO or a dichromate. Amt. of potatssium chlorate is 40-60 dry wt.%, and the proportion of ferrophosphorus is in excess of 4 dry wt.%. The ferrophosphorus has a particle size of 5-100 microns. The binder is gelatine, or animal glue and is present as 3-12 dry wt.%. The filler is felspar or another siliceous mineral. The compsn. further contains up to 10 dry wt.% of iron oxide as pigment. The density of the formulation when in the form of a wet compsn. is 1.0-1.4 g/cm3.
Patent DK-0584606-T3 (DK)
Inventor: DALLOCCO TIZIANO
IPC: C08F10/00
Filed: 1993-08-05
Granted: 1997-01-20
Abstract: Catalysts component of the (co)polymerization of alpha-olefins CH2=CHR, wherein R is hydrogen or an alkyl radical having from 1 to 8 carbon atoms, comprising a product of the composition:    VCly . z(b> wherein (b) represents an organic compound selected from alkyl, aryl and acyl halides, y is a number higher than 2 and lower than 4, and preferably comprised between 2.5 and 3.5 and z is a number higher than zero and lower than or equal to 2, and preferably between 0.002 and 1. Components can be obtained as products of the reaction, carried out at temperatures higher than 10 DEG C, between VCl4 and the compound (b). Particularly preferred among compounds (b) are benzoyl chloride, p-methoxybenzoyl chloride and p-chloro benzoyl chloride. From the components of the invention, either supported or not, catalysts having high activity particularly useful for the production of ethylene polymers showing broad molecular weight distribution can be prepared.
Patent DK-0659389-T3 (DK)
Inventor: GIANOTTI MARC
IPC: A61F2/88
Filed: 1993-10-20
Granted: 1999-02-15
Abstract: An endoprosthesis for implantation in vessels of the human or animal body is designed as a tubular framework of filaments which are arranged in a helical line configuration and which form two entwined groups which run in opposite senses of rotation and in each case consist of a plurality of mutually twisted filaments. Each filament has a composite material (2) with continuous reinforcement fibres (4) made of high-strength inorganic material, preferably carbon, glass or Kevlar, which are embedded in a support material (3) made of a high-strength thermoplastic, preferably polyetheretherketone (PEEK) or polyether sulphone (PS). The composite material (2) can be surrounded by a sleeve (5) which is preferably made of material corresponding to the support material (3), but which can contain admixtures, for example medicaments. In order to accommodate medicaments or other active substances, the sleeve (5) can be designed to be porous. An X-ray contrast medium may be admixed to the material of the sleeve or the support material. To produce the composite material (2), the reinforcement fibres (4) are covered with support material in powder form and are pulled through a heated die - pultruded. The sleeve (5) can then be applied to the composite material (2) in a similar manner. In order to generate a porous structure, a granular and soluble material such as salt can be admixed with the sleeve material and is then washed out. <IMAGE>
Patent DK-0618443-T3 (DK)
Inventor: HOENES JOACHIM DR
IPC: G01N21/86
Filed: 1994-03-18
Granted: 1999-02-15
Abstract: Apparatus to read and evaluate a test strip impregnated with a fluid, has a vertical support and press unit (33) at the test strip holder (3), against the centre plane (22) of the test field zone (13). In the measurement position, the press unit (33) is pressed against the second side (34) of the test strip (4) between the support (24) and the test field zone (13), so that the test strip (4) is bent under tension towards the measurement opening. The test field zone (13) is forced against the test strip laying surface (20) with the measurement opening (23), so that the defined gap of at least one test field (6) is secured by the measurement unit (11).
Patent DK-0668138-T3 (DK)
Inventor: GRAAB GERHARD DR
IPC: B29C43/30
Filed: 1994-10-26
Granted: 1999-08-16
Abstract: A multicolored, patterned floor covering is disclosed along with a method for its manufacture. The floor covering is made of a sheeting which has a first color, and a granular material dyed differently from the sheeting which is embedded in the sheeting along at least in the area of the top side. The sheeting and the granular material consist of cross-linkable, elastomeric materials, the granular material comprising particles which have at least two subregions dyed differently from each other and from the sheeting. The quantity and color of the fractions of each component as selected so that the mixed color resulting from an homogeneous intermixing of all the components contained in the floor covering agrees with the first color.
Patent DK-0612530-T3 (DK)
Inventor: KUMAZAWA EITARO
IPC: A61P17/02
Filed: 1994-02-22
Granted: 2001-03-05
Abstract: This invention provides pharmaceutical preparations containing highly concentrated tumor cytotoxic factor (TCF). The pharmaceutical prparations of the present invention contain highly concentrated TCF and a basic amino acid or their salts, or an organic or inorganic salt as a solubizer. The resultant compositions described in the present invention dissolve TCF at high concentrations of 10 mg/ml or over under about neutral and isotonic conditions. The resultant compositions are stable and are suitable for injection preparations.
Patent DK-0703739-T3 (DK)
Inventor: GRUNENBERG BERNHARD
IPC: B05B7/00
Filed: 1994-06-07
Granted: 1998-05-11
Abstract: PCT No. PCT/EP94/01853 Sec. 371 Date Feb. 2, 1996 Sec. 102(e) Date Feb. 2, 1996 PCT Filed Jun. 7, 1994 PCT Pub. No. WO94/28759 PCT Pub. Date Dec. 22, 1994An aerosol-foam dispenser head is mounted on a container which holds a solution of an active substance and an insoluble, gaseous propellant, and which opens a valve in the container when actuated. The dispenser head has, at the near end of its outlet channel, a throttled aperture with a relatively small flow cross section. Located in the wall of the channel, downstream of the aperture is at least one opening connecting with the atmosphere, the cross section of the opening being significantly greater than that of the throttled aperture. Located at the far end of the channel is a fine-mesh grating or screen.
Patent DK-0696501-T3 (DK)
Inventor: OENBRINK GEORG
IPC: B32B27/08
Filed: 1995-06-19
Granted: 1999-10-25
Abstract: Thermoplastic multilayer composites comprise (I) layer(s) of polyamide and (II) layer(s) of polyalkyl (meth)acrylate, adhesively bonded with (III) adjacent layer(s) of a coupling agent (CA).
Patent DK-0693285-T3 (DK)
Inventor: CULLINAN GEORGE JOSEPH
IPC: A61K31/663
Filed: 1995-07-20
Granted: 2002-05-27
Abstract: The present invention provides a method for inhibiting bone loss comprising administering to a human in need thereof a first compound selected from 1) triarylethylenes; 2) 2,3-diaryl-2H-1-benzopyrans, 3) 1-aminoalkyl-2-phenylindoles; 4) 2-phenyl-3-aroylbenzothiophenes, 5) 1-substituted-2-aryl-dihydronaphthalenes; or 6) benzofurans, and a second compound being a bisphosphonate: or pharmaceutically acceptable salts and solvates thereof. Also encompassed by the invention are combination pharmaceutical formulations and salts.
Patent DK-0726955-T3 (DK)
Inventor: DUNN JOHN J
IPC: A61K39/00
Filed: 1994-10-27
Granted: 2004-08-09
Abstract: Novel chimeric nucleic acids, encoding chimeric Borrelia proteins consisting of at least two antigenic polypeptides from corresponding and/or non-corresponding proteins from the same and/or different species of Borrelia, are disclosed. Chimeric proteins encoded by the nucleic acid sequences are also disclosed. The chimeric proteins are useful as vaccine immunogens against Lyme borreliosis, as well as for immunodiagnostic reagents.
Patent DK-0682664-T3 (DK)
Inventor: HELLBERG MARK
IPC: C07D471/04
Filed: 1994-12-07
Granted: 2001-07-16
Abstract: Compounds having both calcium antagonist and antioxidant activity are disclosed. The compounds are useful in preventing or alleviating damage to tissues at the cellular level. Methods of treatment which employ these properties of the compounds and corresponding pharmaceutical compositions are also disclosed.
Patent DK-0779888-T3 (DK)
Inventor: R DEN VON THOMAS
IPC: A61P9/00
Filed: 1995-09-05
Granted: 1999-10-25
Abstract: The present invention relates to pyrimido[5,4-d]pyrimidines of the general formula    <IMAGE>  (I)  in which Ra to Rc are as defined herein, their tautomers, their stereoisomers and their salts, in particular their physiologically tolerated salts with inorganic or organic acids or bases which have valuable pharmacological properties, in particular an inhibiting action on signal transduction mediated by tyrosine kinases, their use for the treatment of diseases, in particular tumor diseases.
Patent DK-0811035-T3 (DK)
Inventor: METZEMACHER HEINZ-DIETER
IPC: C08K9/04
Filed: 1996-02-22
Granted: 1999-12-20
Abstract: PCT No. PCT/EP96/00743 Sec. 371 Date Aug. 25, 1997 Sec. 102(e) Date Aug. 25, 1997 PCT Filed Feb. 22, 1996 PCT Pub. No. WO96/26240 PCT Pub. Date Aug. 29, 1996A filler composition for thermoplastic olefins or thermoplastic elastomers which comprises a halogen-free, flame-inhibiting filler which has been surface-treated with fatty acid derivatives and optionally a siloxane derivative.
Patent DK-0839028-T3 (DK)
Inventor: HAEBERLIN BARBARA
IPC: C07D/
Filed: 1996-07-12
Granted: 2004-06-01
Abstract: A pharmaceutical composition for oral administration in the form of a solid dispersion comprising an ascomycin or a derivative thereof and a carrier medium.
Patent DK-0870044-T3 (DK)
Inventor: EINERHAND MARKUS PETER WILHELM
IPC: C12N7/00
Filed: 1996-11-29
Granted: 2004-08-02
Abstract: PCT No. PCT/NL96/00472 Sec. 371 Date Jun. 29, 1998 Sec. 102(e) Date Jun. 29, 1998 PCT Filed Nov. 29, 1996 PCT Pub. No. WO97/20943 PCT Pub. Date Jun. 12, 1997The invention is in the field of recombinant genetic materials, especially for use in gene therapy. Vectors used for transferring additional genetic information to cells in the field of gene therapy are often based on viruses. A group of viruses which has been proposed to use for transfection is the group of parvoviruses, in particular the use of adeno associated virus has been proposed. The invention provides improved methods and means for gene therapy and for preparing products to be used in gene therapy using parvovirus based materials. The invention particularly provides regulated expression of genes under control of the combination of a repressor moiety and an activator moiety, particularly for expression of products which are toxic to the host cell in which they are expressed. In this way it is possible to achieve stable transfection for expression of parvovirus toxic proteins so that amongst others a packaging cell line for producing recombinant parvovirus, in particular adeno associated virus is provided as well as virus produced therewith.
Patent DK-0848385-T3 (DK)
Inventor: COGEN JEFFREY MORRIS
IPC: C08L23/02
Filed: 1997-12-10
Granted: 2004-03-29
Abstract: A cable construction comprising the following components: (i) a plurality of insulated electrical conductors having interstices therebetween, the insulation comprising (a) one or more polyolefins selected from the group consisting of polyethylene, polypropylene, and mixtures thereof, and, blended therewith, (b) a mixture containing one or more alkylhydroxy-phenylalkanoyl hydrazines and one or two functionalized hindered amines; (ii) hydrocarbon cable filler grease within the interstices; and (iii) a sheath surrounding components (i) and (ii); wherein said hindered amines have the following structural formulae in which n is 2 to 10: <CHEM>   <CHEM>
Patent DK-0959931-T3 (DK)
Inventor: ARNETT JEFFERY D
IPC: A61M5/32
Filed: 1997-02-13
Granted: 2003-03-24
Abstract: The present invention is directed to a needle guard assembly including a needle, a body and a handle. The body defines a chamber for receiving the needle. The handle moves the needle from the exterior of the body into the chamber.
Patent DK-0899064-T3 (DK)
Inventor: BONE DANIEL
IPC: B25F3/00
Filed: 1998-08-13
Granted: 2002-02-11
Abstract: A power tool comprises a body (14) having a motor (22) with an output. A detachable tool head (50) is engageable with the motor output wherein the motor output has a first engagement means (32) for complimentary engagement with a second engagement means (62) on the tool head drive. The first engagement means (32) is recessed within the body (14) and accessible through an aperture (44) therein. And the second engagement means (62) is recessed within the tool head (52) and accessible through a second aperture therewithin. <IMAGE>
Patent DK-0996694-T3 (DK)
Inventor: WITT-NUESSLEIN SANDRA
IPC: C09J1/00
Filed: 1998-07-15
Granted: 2003-03-31
Abstract: The invention relates to an agglomerate containing at least one of the following water-soluble or water-dispersible materials as a bonding base polymer: carboxylized and/or alkoxylized starch, cellulose ether and fully synthetic vinyl polymers and/or polyacrylates. The agglomerate is characterized in that it contains a blasting agent which produces a high swelling pressure, but, advantageously, does not gel. The agglomerate can have a regular geometric form or not. Its weight should be between 0.5 and 500 g. The agglomerate is used in particular in the production of lump-free paste.
Patent DK-1012212-T3 (DK)
Inventor: BIER PETER
IPC: C09D4/00
Filed: 1998-08-17
Granted: 2002-05-21
Abstract: The present invention provides a coating composition which comprises at least one silicon compound (A) which has at least one radical which is bonded directly to Si, is not able to be separated hydrolytically and contains an epoxy group, a particulate material (B) which is selected from among oxides, oxide hydrates, nitrides and carbides of Si, Al and B and of transition metals and has a particle size within the range 1 to 100 nm, an Si, Ti, Zr, B, Sn or V compound (C) and at least one hydrolysable Ti, Zr or Al compound (D), which comprises the following ratio1.0 mol of the silicon compound (A),0.27 to 0.49 mol of the particulate material (B),0.36 to 0.90 mol of the compound (C) and0.14 to 0.22 mol of the compound (D).
Patent DK-1042305-T3 (DK)
Inventor: KHIRE UDAY
IPC: C07D263/58
Filed: 1998-12-22
Granted: 2005-09-19
Abstract: This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases and proteolytic enzyme mediated diseases, and pharmaceutical compositions for use in such therapy.